Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised sequential cross-over micro-dose trial of dasiglucagon vs glucagon in type 1 diabetes
2016-002617-21Phase 2Completed
- Sponsor
- Zealand Pharma
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of dasiglucagon in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Zealand Pharma. Started Sep 2016; status: completed.
02
Drugs
dasiglucagon
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2016-002617-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002617-21.